VBI VACCINES INC. (TSE:VBV) Files An 8-K Other Events


VBI VACCINES INC. (TSE:VBV) Files An 8-K Other Events
Item 8.01 Other Events.

On June 19, 2018, VBI Vaccines Inc. issued a press release announcing that Jeff Baxter, President and CEO, will present at the JMP Securities Life Sciences Conference on Thursday, June 21, 2018, at 10:30 a.m. ET at the St. Regis Hotel in New York. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press Release dated June 19, 2018

VBI Vaccines Inc/BC Exhibit
EX-99.1 2 ex99-1.htm     VBI Vaccines to Present at 2018 JMP Securities Life Sciences Conference   CAMBRIDGE,…
To view the full exhibit click here


VBI Vaccines Inc. is a development-stage biotechnology company. The Company’s principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company’s subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).